Regitry building and biological sample banking of moyamoya disease in Japa
Not Applicable
- Conditions
- moyamoya disease
- Registration Number
- JPRN-UMIN000029195
- Lead Sponsor
- Hokkaido University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 900
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who deny to participate in this study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Stroke and radiographical progression of vascular disease.
- Secondary Outcome Measures
Name Time Method Analysis of genome and epigenome by using blood, cerbrospinal fluid and saliva. Change of acitivities of daily living (ADL) and life history such as pregancy or delivery
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie moyamoya disease pathogenesis in the JMR registry cohort?
Are there novel drug targets identified in the JMR biological sample bank for moyamoya disease?
What biomarkers correlate with clinical outcomes in the JMR observational study of moyamoya disease?
How does the JMR registry compare to global moyamoya disease registries in terms of genetic and clinical data?
What adverse events are associated with current surgical treatments for moyamoya disease in Japan?